| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |